Rodrigo Carrasco
@rcarrascoloza
Followers
10
Following
142
Statuses
26
Cardiologist, Cardio-oncologist, MD PhD, Scientist
Zug, Switzerland
Joined March 2023
@RiveraTheurel @dineshpmcc1 @husam247 @Coleenten @drchrisyu @InbarNardi @PMunkCardiacCtr @UHN @CCardiacON The best team!👏👏👏
0
0
1
0
0
2
0
0
0
@RiveraTheurel @SCC_CCS @SIAC_cardio @dineshpmcc1 @husam247 @PMunkCardiacCtr @adribaran @oscaar84 @dramcarrillo9 The Dream Team!!!👏👏👏
0
0
4
0
0
0
RT @RiveraTheurel: Cardiac Rehab can be an important therapeutic tool in ATTR-CM 👇🏼@DrDiegoDelgado, #amyloidosis #cardiacamyloidosis #cardi…
0
5
0
RT @dineshpmcc1: Tremendous work by @drchrisyu @Coleenten to bring this pilot data together. This data along with feedback from the interna…
0
4
0
RT @drchrisyu: Our #cardioonc pilot data in @JACCJournals ( shows it may potentially be safe to stop #HeartFailure…
0
8
0
RT @drchrisyu: Our recent #cardioonc work ( showed baseline LA strain is not predictive of #cardiotoxicity in the #…
0
8
0
RT @husam247: Dear #cardiooncology colleagues, We are planning a RCT to test less frequent cardiac imaging during HER2 targeted therapy for…
0
32
0
RT @AnaBaracCardio: Key lessions by phenomenal @dineshpmcc1 on gaps #whyCMR in #CardioOnc 1. Learn from positive and negative studies, 2.…
0
16
0
RT @dineshpmcc1: 2/2 #cardioonc needs RCTs - observational studies remain essential to generate hypothesis and fuel RCTs!!
0
1
0
RT @dineshpmcc1: 1/2 Thanks Ron! I think you summarized our work perfectly "good rationale for RCT" – exactly as our conclusion. Given obse…
0
2
0
RT @JACCJournals: #SGLT2 inhibitors do it again? Data from Drs. @husam247, @dineshpmcc1, et al suggest SGLT2is may reduce the rate of #Hear…
0
73
0
RT @JACCJournals: Do #SGLT2i have a role in #CardioOnc? Dr. @husam247 and team show that they may reduce the rate of #heartfailure hospita…
0
68
0
@husam247 @dineshpmcc1 @Stats_research @IlianaLega @Padma_Kaul @TomasNeilan @trogersresearch @HeartandStroke @WCHospital Congratulations @husam247 !!
0
0
2
RT @husam247: This was a challenging study and I am grateful for the support of @dineshpmcc1 @Stats_research @IlianaLega @Padma_Kaul @rcarr…
0
3
0
RT @husam247: Caveat emptor! These are observational data and patients were quite different, so should NOT start using SGLT2I' without curr…
0
2
0
RT @husam247: There were no safety signals. HR for death trended towards benefit (HR 0.63; 95% CI 0.36-1.11). Diabetes compl'ns, incl ketoa…
0
2
0
RT @husam247: There were no hospitalizations for HF in the SGLT2i group (HR zero!). The HR any HF diagnosis indicated possible benefit (HR…
0
2
0